Prolonged elevation of cytokine levels after human acute ischaemic stroke with evidence of individual variability

Journal of Neuroimmunology

Volumn 246, Issue 1-2, 2012, Pages 78-84

  Yan, Jun ^a   Greer, Judith M ^a   McCombe, Pamela A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cytokines; IL 10; IL 6; Stroke; T cells; TGF beta

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL;

BRAIN ISCHEMIA; CYTOKINES; FEMALE; HUMANS; INDIVIDUALITY; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-6; MALE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 84860129424     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.02.013     Document Type: Article

References (44)

1. Al-Bahrani A., Taha S., Shaath H., Bakhiet M. TNF-alpha and IL-8 in acute stroke and the modulation of these cytokines by antiplatelet agents. Curr. Neurovasc. Res. 2007, 4:31-37.
2. Arumugam T.V., Granger D.N., Mattson M.P. Stroke and T-cells. Neuromolecular Med. 2005, 7:229-242.
3. Bamford J., Sandercock P., Dennis M., Burn J., Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991, 337:1521-1526.
4. Brott T., Adams H.P., Olinger C.P., et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989, 20:864-870.
5. Chang L.T., Yuen C.M., Liou C.W., et al. Link between interleukin-10 level and outcome after ischemic stroke. Neuroimmunomodulation 2010, 17:223-228.
6. Doyle K.P., Cekanaviciute E., Mamer L.E., Buckwalter M.S. TGFbeta signaling in the brain increases with aging and signals to astrocytes and innate immune cells in the weeks after stroke. J. Neuroinflammation 2010, 7:62.
7. Emsley H.C., Smith C.J., Gavin C.M., et al. An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J. Neuroimmunol. 2003, 139:93-101.
8. Emsley H.C., Smith C.J., Gavin C.M., et al. Clinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production. BMC Neurol. 2007, 7:5.
9. Fishman D., Faulds G., Jeffery R., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 1998, 102:1369-1376.
10. Flori L., Gao Y., Laloe D., et al. Immunity traits in pigs: substantial genetic variation and limited covariation. PLoS One 2011, 6:e22717.
11. Gargano J.W., Reeves M.J. Sex differences in stroke recovery and stroke-specific quality of life: results from a statewide stroke registry. Stroke 2007, 38:2541-2548.
12. Giannoudis P.V., Smith R.M., Perry S.L., Windsor A.J., Dickson R.A., Bellamy M.C. Immediate IL-10 expression following major orthopaedic trauma: relationship to anti-inflammatory response and subsequent development of sepsis. Intensive Care Med. 2000, 26:1076-1081.
13. Hendrix S., Nitsch R. The role of T helper cells in neuroprotection and regeneration. J. Neuroimmunol. 2006, 184:100-112.
14. Hoffmann S.C., Stanley E.M., Darrin C.E., et al. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes. Transplantation 2001, 72:1444-1450.
15. Kim J.S., Yoon S.S., Kim Y.H., Ryu J.S. Serial measurement of interleukin-6, transforming growth factor-beta, and S-100 protein in patients with acute stroke. Stroke 1996, 27:1553-1557.
16. Kim H.M., Shin H.Y., Jeong H.J., et al. Reduced IL-2 but elevated IL-4, IL-6, and IgE serum levels in patients with cerebral infarction during the acute stage. J. Mol. Neurosci. 2000, 14:191-196.
17. Kim I.Y., Kim M.M., Kim S.J. Transforming growth factor-beta: biology and clinical relevance. J. Biochem. Mol. Biol. 2005, 38:1-8.
18. Klava A., Windsor A.C., Farmery S.M., et al. Interleukin-10. A role in the development of postoperative immunosuppression. Arch. Surg. 1997, 132:425-429.
19. Kostulas N., Pelidou S.H., Kivisakk P., Kostulas V., Link H. Increased IL-1beta, IL-8, and IL-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study. Stroke 1999, 30:2174-2179.
20. Iadecola C., Anrather J. The immunology of stroke: from mechanisms to translation. Nat. Med. 2011, 17:796-808.
21. Li H.L., Kostulas N., Huang Y.M., et al. IL-17 and IFN-gamma mRNA expression is increased in the brain and systemically after permanent middle cerebral artery occlusion in the rat. J. Neuroimmunol. 2001, 116:5-14.
22. Li G.Z., Zhong D., Yang L.M., et al. Expression of interleukin-17 in ischemic brain tissue. Scand. J. Immunol. 2005, 62:481-486.
23. McCombe P.A., Read S.J. Immune and inflammatory responses to stroke: good or bad?. Int. J. Stroke 2008, 3:254-265.
24. McCombe P.A., Greer J.M., Mackay I.R. Sexual dimorphism in autoimmune disease. Curr. Mol. Med. 2009, 9:1058-1079.
25. Nayak A.R., Kashyap R.S., Purohit H.J., Kabra D., Taori G.M., Daginawala H.F. Evaluation of the inflammatory response in sera from acute ischemic stroke patients by measurement of IL-2 and IL-10. Inflamm. Res. 2009, 58:687-691.
26. Nilupul P.M., Ma H.K., Arakawa S., et al. Inflammation following stroke. J. Clin. Neurosci. 2006, 13:1-8.
27. Papanicolaou D.A., Wilder R.L., Manolagas S.C., Chrousos G.P. The pathophysiologic roles of interleukin-6 in human disease. Ann. Intern. Med. 1998, 128:127-137.
28. Plackett T.P., Gamelli R.L., Kovacs E.J. Gender-based differences in cytokine production after burn injury: a role of interleukin-6. J. Am. Coll. Surg. 2010, 210:73-78.
29. Sabat R., Grutz G., Warszawska K., et al. Biology of interleukin-10. Cytokine Growth Factor Rev. 2010, 21:331-344.
30. Schwartz M., Kipnis J. Protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries. Trends Mol. Med. 2001, 7:252-258.
31. Schwartz M., Cohen I., Lazarov-Spiegler O., Moalem G., Yoles E. The remedy may lie in ourselves: prospects for immune cell therapy in central nervous system protection and repair. J. Mol. Med. 1999, 77:713-717.
32. Silva G.S., Lima F.O., Camargo E.C., et al. Gender differences in outcomes after ischemic stroke: role of ischemic lesion volume and intracranial large-artery occlusion. Cerebrovasc. Dis. 2010, 30:470-475.
33. Slevin M., Krupinski J., Slowik A., Kumar P., Szczudlik A., Gaffney J. Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke. Stroke 2000, 31:1863-1870.
34. Smith C.J., Emsley H.C., Gavin C.M., et al. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol. 2004, 4:2.
35. Sperry J.L., Friese R.S., Frankel H.L., et al. Male gender is associated with excessive IL-6 expression following severe injury. J. Trauma 2008, 64:572-578.
36. Stanzani L., Zoia C., Sala G., et al. Nerve growth factor and transforming growth factor-beta serum levels in acute stroke patients. Possible involvement of neurotrophins in cerebrovascular disease. Cerebrovasc. Dis. 2001, 12:240-244.
37. Vila N., Castillo J., Davalos A., Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 2000, 31:2325-2329.
38. Vila N., Castillo J., Davalos A., Esteve A., Planas A.M., Chamorro A. Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke. Stroke 2003, 34:671-675.
39. Waje-Andreassen U., Krakenes J., Ulvestad E., et al. IL-6: an early marker for outcome in acute ischemic stroke. Acta Neurol. Scand. 2005, 111:360-365.
40. Welsh P., Barber M., Langhorne P., Rumley A., Lowe G.D., Stott D.J. Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke. Cerebrovasc. Dis. 2009, 27:247-253.
41. Whiteley W., Jackson C., Lewis S., et al. Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS Med. 2009, 6:e1000145.
42. Yan J., Greer J.M., Etherington K., et al. Immune activation in the peripheral blood of patients with acute ischemic stroke. J. Neuroimmunol. 2009, 206:112-117.
43. Yan J., Read S.J., Henderson R.D., et al. Frequency and function of regulatory T cells after ischaemic stroke in humans. J. Neuroimmunol. 2012, 243:89-94.
44. Zaremba J., Losy J. Interleukin-18 in acute ischaemic stroke patients. Neurol. Sci. 2003, 24:117-124.